Oncology PracticeTIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaImmunotherapyImmuno-oncologyPatient & Survivor CarePractice ManagementBusiness of MedicineMixed Topics
Oncology PracticeResidents Unionizing: What Are the Benefits, the Downsides?March 7, 2024Business of MedicinePractice Management
Oncology PracticeHow the Change Healthcare Cyberattack Affects Oncology CareMarch 7, 2024Practice Management
Hematology NewsPfizer Antibody-Drug Conjugate Picks Up Pediatric ALL IndicationMarch 7, 2024ALLPediatrics
Oncology PracticeStudy Finds No Increased Cancer Risk With SpironolactoneMarch 7, 2024Mixed TopicsBreast Cancer
Hematology NewsMedicare Pay Bump Provision in Federal Bill Falls Short, Doc Groups SayMarch 7, 2024Business of MedicinePractice Management
Oncology PracticeFirst Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024Lymphoma & Plasma Cell DisordersGenitourinary CancerBreast CancerMultiple Myeloma
Oncology PracticeHow These MDs Conquered Imposter SyndromeMarch 6, 2024Business of MedicinePractice Management
Oncology PracticeIs Primary Tumor Resection Beneficial in Stage IV CRC?March 6, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Oncology PracticeWhat Is the Long-Term Mortality Risk for Men With HR+ Breast Cancer?March 6, 2024Breast CancerPatient & Survivor Care
Hematology NewsCan Changes to Chemo Regimens Improve Drug Tolerability in Older Patients?March 5, 2024Patient & Survivor CarePreventive Care
Oncology PracticeOutside the Guidelines: Denosumab Overuse in Prostate CancerMarch 4, 2024Genitourinary CancerBusiness of MedicinePractice ManagementProstate Cancer
Oncology PracticeFDA Approves Amivantamab First-line Indication for NSCLCMarch 4, 2024Lung CancerPatient & Survivor Care
Oncology PracticeOlder Age Confers a Higher Risk for Second Primary Melanoma: StudyMarch 4, 2024Melanoma
